Could autoantibodies predict future disease in healthy people? (pp 1544)May 05, 2004A review article in this week's issue of THE LANCET discusses how autoantibody detection in the blood of healthy individuals could have potential as a marker for future autoimmune diseases such as Rheumatoid arthritis and Lupus syndrome. Hal Scofield from the Oklahoma Research Foundation, USA, discusses recent evidence suggesting that autoantibodies (antibodies that attack the body's own tissue) are often apparent several years before an illness becomes manifest. He cites recent research among people with rheumatoid arthritis where specific autoantibodies were detected more than four years before the onset of disease symptoms. Professor Scofield comments: "the data indicate that autoimmune disease is preceded by a long preclinical phase in which individuals can be identified by the presence of autoantibodies. Such identification might allow immunological treatment whereby disease is prevented, as is already being studied in diabetes. Alternatively, even if disease cannot be prevented, perhaps life-threatening but treatable conditions could be avoided, such as diabetic coma as well as severe, acute complications of untreated Addison's disease (adrenal-gland failure) or Graves' disease (overactive thyroid gland). For all these diseases, except type 1 diabetes, further work is needed to assess the natural history of disease progression and predictive value of autoantibodies in healthy individuals". | |||||||||||||||||||||
|
Related Diabetes Current Events and Diabetes News Articles Pure insulin-producing cells produced in mouse Singapore researchers have developed an unlimited number of pure insulin-producing cells from mouse embryonic stem cells (ESCs). Researcher tricks immune system in diabetic mice The body's immune system hates strangers. When its security patrol spots a foreign cell, it annihilates it. Systems biology brings hope of speeding up drug development Almost every day brings news of an apparent breakthrough against cancer, infectious diseases, or metabolic conditions like diabetes, but these rarely translate into effective therapies or drugs, and even if they do clinical development usually takes well over a decade. Garlic chemical tablet treats diabetes I and II A drug based on a chemical found in garlic can treat diabetes types I and II when taken as a tablet, a study in the new Royal Society of Chemistry journal Metallomics says. Very low birth weight is a risk factor for 1 cause of CKD Individuals who were underweight at birth are at increased risk of developing a condition called secondary focal segmental glomerulosclerosis, according to a study appearing in the January 2009 issue of the Clinical Journal of the American Society Nephrology (CJASN). New insight into the controls on a go-to enzyme Scientists at St. Jude Children's Research Hospital have gained new insights into regulation of one of the body's enzyme workhorses called calpains. Survival of head and neck cancer patients is greatly affected by coexisting ailments Current estimates for head and neck cancer survival are largely inaccurate because they widely disregard many of the most common diseases such patients have in addition to their primary cancer, says Jay Piccirillo, M.D., a head and neck specialist at Washington University School of Medicine in St. Louis, the Siteman Cancer Center and Barnes-Jewish Hospital. JDRF funded research shows promise for prevention, reversal of type 1 diabetes Researchers at the University of California, San Francisco have reported that two common cancer drugs have been used to block and reverse type 1 diabetes in mice. New imaging technique tracks cancer-killing cells over prolonged period Coaxing a patient's own cells to hunt down and tackle infected or diseased cells is a promising therapeutic approach for many disorders. Vitamin C lowers levels of heart disease biomarker, finds study, adds to debate of health benefits A new study led by researchers at the University of California, Berkeley, adds to the evidence that vitamin C supplements can lower concentrations of C-reactive protein (CRP), a central biomarker of inflammation that has been shown to be a powerful predictor of heart disease and diabetes. More Diabetes Current Events and Diabetes News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||